The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA VISN 22) awarded a two-year, $160,000 firm fixed price purchase order to Vectorbuilder Inc. for molecular cloning services. Under this contract, Vectorbuilder will provide cloning of DNA fragments and plasmids to support research and development activities within VISN 22, which oversees VA medical centers and clinics in northern Illinois and parts of Indiana. No subcontractors or...
Vectorbuilder Inc. has been awarded a firm fixed price purchase order in the amount of $11,437 by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases to provide custom adeno-associated virus packaging. No set-aside designation was applied to this procurement. Per the award description, Vectorbuilder will deliver molecular cloning services to support the NIDDK's biomedical research efforts. As a global leader in gene delivery technologies,...
The National Institute of Neurological Disorders and Stroke, a component of the National Institutes of Health, awarded a $15,238 firm fixed price purchase order to Vectorbuilder Inc. for AAV8 large-scale 10 and ultra-purification packaging services. The contract has an ultimate completion date of August 26, 2025. Vectorbuilder is a specialized biotechnology company that provides gene delivery and molecular biology services to various federal agencies, including the Department of Veterans Affairs...
This purchase order awards Vector Biosystems, Inc., doing business as Vector Biolabs, $12,060 to deliver two custom adeno-associated viral constructs to the National Center for Advancing Translational Sciences within the Department of Health and Human Services' National Institutes of Health. Specifically, Vector Biosystems will provide one AAV6 vector containing GFP and an shRNA targeting human COLQ, and one AAV6 vector containing GFP and an shRNA targeting human DOK7. Both constructs are to...
The U.S. government awarded a $23,434 firm fixed price purchase order contract to Vectorbuilder Inc., a small business biotechnology company, to provide stable cell line generation contract research organization (CRO) services. The contract was awarded by the Shared Services Center, a civilian agency, and has a completion date of March 28, 2025. Vectorbuilder has a proven track record of supporting biomedical research efforts across multiple NIH institutes and the Department of Veterans...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services, awarded a $16,999 firm fixed-price purchase order to Vectorbuilder Inc., a specialized biotechnology company, for large-scale 15 and ultra-purification packaging service for PAAV240227-1016XNQ. The contract, which does not utilize any set-aside designations, has a completion date of September 3, 2025. Vectorbuilder, a global leader in gene delivery...
This firm fixed-price purchase order contract was awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Vector Biosystems, Inc. (doing business as Vector Biolabs), a minority-owned and small disadvantaged for-profit biotechnology company. The $10,870.00 contract is for the delivery of adeno-associated viruses (AAVs) to express mitochondrial and cytosolic-targeted reactive oxygen species (ROS) sensitive proteins. This will support...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 22 awarded a definitive contract to Vigene Biosciences, Inc., a minority-owned, for-profit small business, to provide laboratory testing services as well as virus-related products such as Anti-HER2 CAR-T Lentivirus Particles, Clinical Grade Virus Vectors, and Viruses: PAAV-EF1A-DIO_GFP-P2A-GFE3. The contract is a firm-fixed-price contract with a potential value of $131,201.00 and a...
This firm fixed-price contract for $803,500.00 was awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to Vector Biomed Inc. for the production and stability testing of clinical grade lentiviral vector. The services include manufacturing a minimum of 50mg of GMP/clinical grade transfer plasmid and 400ml of concentrated, GMP grade lentiviral vector, as well as performing stability testing...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a purchase order contract valued at one hundred twenty thousand six hundred dollars ($120,600) to Vector Biomed Inc. The contract is to obtain preclinical grade lentiviral vectors in support of NCI's Pediatric Oncology Branch investigational new drug enabling studies and demonstration of clinical-grade vector production feasibility. Services include receipt confirmation...